Fulton Amy M相关文献与解析，生知库 | 链接生命科学的每一步

Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.

多药耐药相关蛋白（MRP4）输出前列腺素E2（PGE2），促进基底细胞型/三阴性乳腺癌的转移

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.14145

Kochel Tyler J, Reader Jocelyn C, Ma Xinrong, Kundu Namita, Fulton Amy M

Upregulation of Cyclooxygenase-2/Prostaglandin E2 (COX-2/PGE2) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer.

三阴性乳腺癌中环氧合酶-2/前列腺素E2 (COX-2/PGE2) 通路成员多药耐药相关蛋白4 (MRP4) 上调，前列腺素转运蛋白 (PGT) 和15-前列腺素脱氢酶 (15-PGDH) 下调。

期刊:Breast Cancer-Basic and Clinical Research

影响因子:1.9

doi:10.4137/BCBCR.S38529

Kochel Tyler J, Goloubeva Olga G, Fulton Amy M

Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis

CXCR3亚型在促进癌症干细胞样细胞存活和转移中发挥着不同的作用

期刊:Breast Cancer Research and Treatment

影响因子:3

doi:10.1007/s10549-014-3229-7

Li, Yanchun; Reader, Jocelyn C; Ma, Xinrong; Kundu, Namita; Kochel, Tyler; Fulton, Amy M

Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2

弗朗多苷A抑制乳腺癌转移并拮抗前列腺素E受体EP4和EP2。

期刊:Breast Cancer Research and Treatment

影响因子:3

doi:10.1007/s10549-011-1675-z

Ma, Xinrong; Kundu, Namita; Collin, Peter D; Goloubeva, Olga; Fulton, Amy M

Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities

前列腺素E受体EP1抑制乳腺癌转移，并与生存率差异和癌症差异有关。

期刊:Molecular Cancer Research

影响因子:4.7

doi:10.1158/1541-7786.MCR-10-0003

Ma, Xinrong; Kundu, Namita; Ioffe, Olga B; Goloubeva, Olga; Konger, Raymond; Baquet, Claudia; Gimotty, Phyllis; Reader, Jocelyn; Fulton, Amy M

Eicosanoids in Cancer: Prostaglandin E(2) Receptor 4 in Cancer Therapeutics and Immunotherapy

类花生酸在癌症中的作用：前列腺素E2受体4在癌症治疗和免疫疗法中的应用

Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.

多药耐药相关蛋白（MRP4）输出前列腺素E2（PGE2），促进基底细胞型/三阴性乳腺癌的转移

Upregulation of Cyclooxygenase-2/Prostaglandin E2 (COX-2/PGE2) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer.

三阴性乳腺癌中环氧合酶-2/前列腺素E2 (COX-2/PGE2) 通路成员多药耐药相关蛋白4 (MRP4) 上调，前列腺素转运蛋白 (PGT) 和15-前列腺素脱氢酶 (15-PGDH) 下调。

Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis

CXCR3亚型在促进癌症干细胞样细胞存活和转移中发挥着不同的作用

Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2

弗朗多苷A抑制乳腺癌转移并拮抗前列腺素E受体EP4和EP2。

Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities

前列腺素E受体EP1抑制乳腺癌转移，并与生存率差异和癌症差异有关。